On April 19, 2025, Hunan StarMed Medical Technology Co., Ltd. and the Second Xiangya Hospital of Central South University held a symposium on technological innovation and transformation at Hunan StarMed Medical's headquarters. The event aimed to deepen collaboration among industry, academia, research, and healthcare sectors, fostering medical technology innovation and the translation of research into clinical applications.
During the symposium, Jiang Leyang, General Manager of Hunan StarMed Medical, warmly welcomed Secretary Chai Xiangping and his delegation from the Second Xiangya Hospital. Jiang accompanied the hospital leaders on a tour of the company's automated production lines, R&D center, and physicochemical laboratory. He provided a detailed overview of the company's concept verification platform, micron-level 3D printing system, R&D testing laboratory, successful cases of technology commercialization, and examples of industry-academia-research collaboration. Jiang emphasized the company's commitment to innovation and its development philosophy of breaking barriers in high-end medical technology. He expressed hope that through deep cooperation with the Second Xiangya Hospital, more innovative technologies could transition from the laboratory to clinical settings, empowering precision medicine.
Secretary Chai Xiangping acknowledged Hunan StarMed Medical's innovative capabilities in the medical technology field. He highlighted that the Second Xiangya Hospital, as a top-tier medical institution in China, possesses abundant clinical resources and research expertise. Chai noted that the exchange aimed to establish a collaborative innovation platform between medical institutions and enterprises, accelerating the transformation of medical technologies and enhancing diagnostic and treatment standards to provide high-quality medical services to patients.
This symposium laid a solid foundation for future collaboration between the two parties. Moving forward, Hunan StarMed Medical and the Second Xiangya Hospital will leverage their respective strengths in technological research and clinical practice to jointly advance medical technology innovation, contributing to the development of a healthier China.
